Pharmacogenomics for Precision Medicine
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 March 2025 | Viewed by 2954
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pharmacogenomics is an advanced method of customizing medications to individual patients based on their unique genetic makeup. Rather than relying on a one-size-fits-all approach, this technique considers individual variability. While genetic, epigenetic, and gene-expression variability were once believed to be independent factors of phenotype variation, recent studies have shown that they work in tandem to produce distinct effects of medication on an individual.
Although research has highlighted the significance of genetic factors in drug effects, the widespread use of pharmacogenomics data remains uncommon in many countries. This may be due to several factors, such as researchers' inconsistent interpretation of data or difficulties understanding and applying these results to precision medicine.
This issue invites new research articles representing pharmacogenomics knowledge use in clinical practice (such as a part of precision medicine), economic evaluations of drugs or methods used in therapy, and innovative approaches to educate clinical personnel and high school students on pharmacogenomics and precise treatment.
Dr. Vacis Tatarūnas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenomics in precise therapy
- tailored medicine
- pharmacoeconomics
- personalized medicine
- education in pharmacogenomics and precise medicine
- future directions in pharmacogenomics
- pharmacogenomics and phenotype
- genotype, epigenetic variation, and gene expression axis in pharmacogenomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.